Skip to main content
SpringerLink
Log in

Cannabinoid kann das Fortschreiten der Behinderung nicht bremsen

Multiple Sklerose

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenzen

  1. Zajicek J et al. Lancet 2003; 362: 1517–26

    Article  PubMed  CAS  Google Scholar 

  2. Hampson AJ et al. Proc Natl Acad Sci U S A 1998; 95: 8268–73

    Article  Google Scholar 

  3. Molina-Holgado E et al. J Neurosci 2002; 22: 9742–53

    Google Scholar 

  4. Skaper SD et al. Proc Natl Acad Sci U S A 1996; 93: 3984–9

    Article  PubMed  CAS  Google Scholar 

  5. Zajicek J, Ball S, Wright D et al; on behalf of the CUPID investigator group. Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial. Lancet Neurol 2013; 12: 857–65

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Neurologie, Universitätsklinikum Münster, Münster, Deutschland

    Sven G. Meuth

Authors
  1. Sven G. Meuth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sven G. Meuth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meuth, S. Cannabinoid kann das Fortschreiten der Behinderung nicht bremsen. InFo Neurologie 15, 34 (2013). https://doi.org/10.1007/s15005-013-0653-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-013-0653-x

Search

Navigation